Metformin is one of the most widely used medicines for type 2 diabetes. It lowers blood glucose, has a low risk of hypoglycemia when used alone, is generally weight-neutral or may produce modest weight loss, and is inexpensive and widely available. The American Diabetes Association (ADA) Standards of Care 2026 continues to describe metformin as a commonly used option when the main treatment need is glucose lowering without another comorbidity that changes medication selection.
What is metformin?
Metformin is an oral glucose-lowering medicine belonging to the biguanide class. It primarily reduces hepatic glucose production and improves insulin sensitivity. It does not usually cause hypoglycemia when used as monotherapy because it does not directly stimulate insulin secretion.
How does metformin help in type 2 diabetes?
Metformin can reduce HbA1c and fasting glucose while generally avoiding the weight gain and hypoglycemia associated with some other glucose-lowering medicines. It can be used alone or in combination with other diabetes medicines when additional glycemic control or cardiovascular, kidney or weight-related benefits are needed.
Importantly, diabetes treatment is now increasingly individualized. In people with established or high-risk cardiovascular disease, heart failure or chronic kidney disease, medicines such as GLP-1 receptor agonists and/or SGLT2 inhibitors with demonstrated benefits may be indicated irrespective of HbA1c and whether metformin is being used.
Is metformin the first medicine for diabetes?
Metformin remains a commonly used initial medicine for many adults with type 2 diabetes when there are no contraindications and when the main treatment goal is glucose lowering. However, it is not automatically the best or only medicine for every person. The choice should consider cardiovascular disease, kidney disease, heart failure, obesity, hypoglycemia risk, side effects, cost, access and individual treatment goals.
Common metformin side effects
The most common adverse effects are gastrointestinal. These may include:
- Nausea
- Loose stools or diarrhea
- Bloating
- Abdominal discomfort
- Reduced appetite
These symptoms are often reduced by starting at a lower dose, increasing gradually, taking metformin with food and considering an extended-release formulation when appropriate.
Does metformin cause low blood sugar?
Metformin alone has a low risk of hypoglycemia. However, the risk can change when it is combined with medicines such as insulin or sulfonylureas. If metformin is part of a combination regimen, the overall treatment plan—not metformin alone—determines hypoglycemia risk.
Metformin and kidney function
Kidney function is important when prescribing metformin because the medicine is cleared by the kidneys. The ADA 2026 Standards state that metformin is contraindicated when eGFR is below 30 mL/min/1.73 m². In people with eGFR 30–45 mL/min/1.73 m², treatment requires greater caution and appropriate dose assessment and monitoring.
Metformin-associated lactic acidosis is very rare, but the risk increases in settings such as severe kidney impairment and certain acute illnesses. Metformin may need to be temporarily withheld during situations involving significant dehydration, hypoxia, acute kidney injury or other clinical circumstances where the treating clinician considers it unsafe.
Metformin and vitamin B12 deficiency
Long-term metformin therapy is associated with an increased risk of vitamin B12 deficiency. The ADA 2026 Standards recommend considering periodic B12 assessment, particularly in people taking metformin who have anemia or peripheral neuropathy.
Symptoms such as unexplained anemia, numbness, tingling or worsening neuropathic symptoms should prompt clinical assessment rather than assuming that they are solely due to diabetes.
Can metformin help prevent diabetes?
Metformin can be considered for diabetes prevention in selected adults at high risk of developing type 2 diabetes. The ADA 2026 specifically highlights adults aged 25–59 years with BMI ≥35 kg/m², higher fasting glucose, higher HbA1c and people with a history of gestational diabetes as groups in whom metformin may be particularly considered.
Metformin for prevention should not be viewed as a substitute for lifestyle intervention. Nutrition, physical activity, weight management and regular monitoring remain important components of diabetes prevention.
When might metformin not be enough?
Type 2 diabetes is a progressive and heterogeneous condition. Some people will need more than one glucose-lowering medicine to achieve and maintain their individualized glycemic target.
If a person has established cardiovascular disease, heart failure, chronic kidney disease or obesity, medication selection may be driven by benefits beyond glucose lowering. For example, selected SGLT2 inhibitors and GLP-1-based therapies have demonstrated cardiovascular and/or kidney benefits in appropriate populations.
If blood glucose is very high, especially with symptoms of hyperglycemia, insulin may sometimes be required. The ADA 2026 recommends considering insulin when there is severe hyperglycemia, including A1C above 10% or glucose levels around 300 mg/dL or higher, particularly when symptoms are present.
Metformin: practical tips
- Take it exactly as prescribed.
- Taking it with food can improve gastrointestinal tolerance.
- Do not increase the dose rapidly without medical advice.
- Tell your doctor if you develop persistent vomiting, severe diarrhea or dehydration.
- Have kidney function reviewed as recommended.
- Discuss vitamin B12 testing when taking metformin long term, especially if anemia or neuropathy develops.
- Do not stop or restart diabetes medicines around procedures or acute illness without appropriate medical advice.
Frequently asked questions
Is metformin safe for everyone with diabetes?
No. Metformin is not appropriate for everyone. Kidney function, acute illness, hypoxia, dehydration, liver-related clinical circumstances and other individual factors need to be considered before and during treatment.
Does metformin cause weight loss?
Metformin is generally weight-neutral and may produce modest weight loss in some people. It should not be considered a dedicated weight-loss medicine.
Can metformin be taken with GLP-1 medicines?
Yes, metformin can be combined with GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists when clinically appropriate. Treatment should be individualized according to glycemic goals, weight goals, comorbidities, tolerability and other medicines.
Should metformin be stopped if I have diarrhea?
Persistent diarrhea can cause dehydration and may require medical review. Do not make medication changes based only on a general article; contact your treating clinician for advice, particularly if you are unable to maintain fluids or have significant weakness or reduced urine output.
Bottom line
Metformin remains an important and commonly used medicine for type 2 diabetes. Its advantages include effective glucose lowering, low hypoglycemia risk when used alone, low cost and generally favorable effects on weight. The main issues to watch for are gastrointestinal intolerance, kidney function and vitamin B12 deficiency.
Modern diabetes care is person-centered. Metformin should be viewed as one component of an individualized treatment plan rather than a medicine that every person with type 2 diabetes must take.
For more information about diabetes, thyroid disease and weight management, visit Vishuddha Endocrine Clinic or read our practical guide to diabetes management.
Dr. Moxit Shah, DM Endocrinology
Vishuddha Endocrine Clinic, Ahmedabad
New consultation: ₹1000 | Follow-up: ₹600
Medical disclaimer: This article is for general education. Metformin dose, continuation or discontinuation should be individualized by the treating clinician.
